The power to predict.
Combining the power of next-generation DNA sequencing and advanced machine learning algorithms, our technology has been shown to accurately detect and predict urothelial cancer or its recurrence months or even years before signs and symptoms develop or become detectable by cystoscopy.
UroAmp can predict future cancer risk
months to years before onset of other clues.3
The science powering UroAmp permits ultra-deep interrogation of DNA mutations, the root cause of cancer, and can find a single cancer cell in a background of a thousand normal cells. To do this, we profile a patient’s full genome and make 15 billion measurements per urine sample to analyze 250,000 genomic locations, deeply quantified over 60 genes, to identify 6 different mutation types.